Holen Sie sich die Stockscreener-App
22.47
0.40%
0.09
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - webull.com
STAAR Surgical Company (STAA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday - AOL.com
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday - The Motley Fool
A Look at Staar Surgical Co (STAA) After 7.5% Gain -- GF Value $33.25 vs Price $22.43 - GuruFocus
STAAR Surgical Analyst Turns Bullish On Potential For ‘Meaningful’ Street Upside - Benzinga
Why is STAAR Surgical stock surging today? - Investing.com
STAAR Surgical jumps on Stifel upgrade citing China growth potential - Investing.com
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - The Chronicle-Journal
STAA Upgraded by Stifel -- Price Target Raised to $31 - GuruFocus
Stifel upgrades STAAR Surgical stock rating on China growth outlook - Investing.com
Glucotrack announces pricing of public offering - Medical Buyer
STAAR Surgical approves USD 50M share repurchase - Medical Buyer
Why Staar Surgical Stock Soared Today - The Motley Fool
A Look at Staar Surgical Co (STAA) After 7.5% Gain -- GF Value $33.27 vs Price $20.51 - GuruFocus
STAA Looks 38.4% Undervalued on GF Value™ Despite Profit Challen - GuruFocus
STAAR Surgical stock ticks higher on $50M buyback authorization - Investing.com
Why is STAAR Surgical stock climbing today? By Investing.com - Investing.com Nigeria
Why is STAAR Surgical stock climbing today? - Investing.com
STAAR Surgical authorizes $50 million share buyback program - Investing.com
STAAR Surgical authorizes $50 million share buyback program By Investing.com - Investing.com Nigeria
STAAR Surgical Company (STAA) Stock forecasts - Yahoo Finance Singapore
Is Staar Surgical Co (STAA) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus
Investigation launched into STAAR Surgical for possible fiduciary breaches affecting shareholders. - Pluang
STAA Rated Buy by Jefferies -- Price Target Lowered to $23 - GuruFocus
STAAR Surgical Q2 EPS $0.16 beats $0.15 estimate; sales up 111% - scanx.trade
Cataract Surgery Devices Market Size, Share & Growth Report, 2035 - SNS Insider
STAAR Surgical Company (STAA) Stock Analysis: Exploring a 31% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
A Look at Staar Surgical Co (STAA) After 5.2% Decline -- GF Value $33.38 vs Price $21.24 - GuruFocus
Learn Why The Bull Case For STAAR Surgical Stock Could Change Following Earnings Rebound - Simply Wall Street
Is STAAR Surgical (STAA) A Bargain Following Its Profit Turnaround And China Led Sales Rebound? - simplywall.st
STAAR Surgical (STAA) Swings To Profit On China Rebound - Yahoo Finance
STAAR Surgical (STAA) Says Implantable Lenses Are Taking Share From Laser Surgery - Simply Wall Street
Staar Surgical Co (STAA) Shares Fall 3.4% -- What GF Score of 81 Tells Investors - GuruFocus
STAAR Surgical hires former CEO to lead commercial team - MedTech Dive
STAAR Surgical Names David Bailey as Chief Commercial Officer with Detailed Compensation Package - Kalkine Media
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer - Minichart
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction - Finviz
U.S. laser procedures fell 52% as use of implantable lenses rose 76% - Stock Titan
STAA Looks 29.6% Undervalued on GF Value™ - GuruFocus
Ex-STAAR Surgical CEO David Bailey Rejoins as Chief Commercial Officer - Medical Product Outsourcing
Former CEO returns as STAAR's vision-lens revenue grows more than tenfold - Stock Titan
Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more - glance.eyesoneyecare.com
3 Stocks Riding The Smart Glasses And Eye Care Shift Investors Should Watch - simplywall.st
Why Did STAA Stock Surge More Than 19% After-Hours Today? - Stocktwits
2.06%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):